Pathological factors associated with survival benefit from adjuvant chemotherapy (ACT): a population‐based study of bladder cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-410x|116|3|373-381

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.116, Iss.3, 2015-09, pp. : 373-381

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Perioperative chemotherapy for muscle‐invasive bladder cancer: A population‐based outcomes study

By  

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1630-1638

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population‐based study among older breast cancer patients

By  

CANCER, Vol. 124, Iss. 5, 2018-03 ,pp. : 899-906

John Wiley & Sons Inc

Access to resources Recommend Favorite

Administration of adjuvant chemotherapy for stage II‐III colon cancer patients: An European population‐based study

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 7, 2018-04 ,pp. : 1480-1489

John Wiley & Sons Inc

Access to resources Recommend Favorite

Smoking and survival of colorectal cancer patients: Population‐based study from Germany

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 6, 2015-09 ,pp. : 1433-1445

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetics modify bladder cancer prognosis

By  

BJU INTERNATIONAL, Vol. 115, Iss. 2, 2015-02 ,pp. : 238-247

John Wiley & Sons Inc

Access to resources Recommend Favorite